IL37 and pulmonary fibrosis: Specifically, IL-37 exerts protective effects in diseases such as asthma, pulmonary infections, NSCLC, and pulmonary fibrosis through core mechanisms including inhibition of pro-inflammatory cytokine release, modulation of immune cell functions, regulation of autophagy and apoptosis, as well as suppression of fibrotic formation.